Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus acidophilus L-92 and Improved Immune Function

Research synthesisLow evidenceSmall effect12 studies · 12 beneficial · 0 neutral · 0 harmful

Across 12 studies, all reported beneficial effects on immune function, with a predominant effect size of small. The most direct evidence comes from one randomized controlled trial in adult atopic dermatitis patients (n=50) showing significant immunomodulatory effects, and a large systematic review (n=1502) that generally supports immune benefits from probiotics. Dosing was only specified in one study (heat-killed and dried L-92 daily).

  • Studied populations: adults with atopic dermatitis

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Additionally, most studies are reviews or indirect; only one RCT directly evaluates L-92, and dosing and forms were not consistently reported.

Generated Jul 11, 2026
Doses used in studies
  • CFU/day: 1 (median 1, IQR 11) 1 study
Safety in these studies
12 of 12 papers
Back to top